Annual Drug Patent Expirations for MYCAPSSA
Mycapssa is a drug marketed by Amryt and is included in one NDA. It is available from two suppliers. There are ten patents protecting this drug.
This drug has fifty-eight patent family members in twenty-five countries.
The generic ingredient in MYCAPSSA is octreotide acetate. Two suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
